CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 105 enrolled
Drug / intervention
LSG started 2 cm from the pylorus +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01974388
NCT01974388N/ACompleted
CompareCT.gov

Impact of Extent of Antral Resection on Surgical Outcomes of Sleeve Gastrectomy for Morbid Obesity (A Prospective Randomized Study)

Mansoura University·interventional·Posted Nov 1, 2013·Updated Nov 23, 2015

In Brief

A clinical study evaluating LSG started 2 cm from the pylorus and LSG started 6 cm from pylorus for Obesity. Completed, enrolled 105 participants across 1 site.

Detailed Summary

Laparoscopic sleeve gastrectomy (LSG) is a surgical technique that treats morbid obesity by both restrictive and hormonal action. Consecutive patients with morbid obesity treated by LSG at our department were evaluated. Patients enrolled in the study were randomized into Group I: LSG begin the division 2 cm from the pylorus and Group II: LSG begin the division 6 cm from the pylorus. The primary outcome measure was the % of excess weight loss (%EWL); secondary outcomes included operative time, day to resume oral feeding, postoperative morbidity and mortality, improvement of comorbidity.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity
CountriesEgypt
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 1, 2013
Enrollment StartJan 1, 2008
Primary CompletionJan 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 12.7 years ago

Interventions

LSG started 2 cm from the pylorusprocedure

Laparoscopic sleeve gastrectomy started 2 cm from pylorus

LSG started 6 cm from pylorusprocedure

LSG started 6 cm from pylorus